• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


39.6800 USD 0.2800 0.71%

As of 20:10:00 ET on 04/23/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 39.5500 Day's Range: 38.7300 - 39.8200 Volume: 1,234,916
Previous Close: 39.4000 52wk Range: 20.0200 - 42.4960 1-Yr Rtn: +45.99%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 39.6800
  • 1D
  • 1M
  • 1Y
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 17.0300
Estimated P/E(06/2014) 17.9873
Relative P/E vs. SPX 0.9925
Earnings Per Share (USD) (ttm) 2.3300
Est. EPS (USD) (06/2014) 2.2060
Est. PEG Ratio 1.1754
Market Cap (M USD) 2,895.63
Shares Outstanding (M) 72.97
30 Day Average Volume 2,036,506
Price/Book (mrq) 4.3423
Price/Sale (ttm) 4.2297
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderJames S EvansCFO/Treasurer
Robert Gardner HarrisonChief Information OfficerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil